| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/20/2007 | WO2007105753A1 Triazole derivative or salt thereof |
| 09/20/2007 | WO2007105730A1 Insulin resistance-improving agent |
| 09/20/2007 | WO2007105442A1 Therapeutic agent for food intake disorder or water intake disorder |
| 09/20/2007 | WO2007105286A1 Blood lipid level-lowering agent |
| 09/20/2007 | WO2007105050A1 Dibenzyl amine compounds and derivatives |
| 09/20/2007 | WO2007104905A1 Gastric raft composition comprising preferably processed starches for inducing satiety |
| 09/20/2007 | WO2007104242A1 Compounds capable of inhibiting zinc ion metalloproteinases |
| 09/20/2007 | WO2007086082A3 A process for manufacturing rosuvastatin potassium and crystalline and amorphous forms thereof |
| 09/20/2007 | WO2006017384A3 Indazoles useful in treating cardiovascular diseases |
| 09/20/2007 | WO2005019190A3 (4 -amino -1,2, 5-oxadiazol-4-yl) -hetξroaromatic compounds useful as protein kinase inhibitors |
| 09/20/2007 | US20070219266 N-Acylated-3-(Benzoyl)-Pyrrolidines as 11-Beta-HSD1 Inhibitors Useful for the Treatment of Metabolic Disorders |
| 09/20/2007 | US20070219255 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 09/20/2007 | US20070219233 Substituted Indoles and Their Use as Integrin Antagonists |
| 09/20/2007 | US20070219232 Chemical Compounds |
| 09/20/2007 | US20070219215 Thioamides and Salts Thereof and Cytokine Production Inhibitors Containing Both |
| 09/20/2007 | US20070219202 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease |
| 09/20/2007 | US20070219194 Phenylalanine derivatives |
| 09/20/2007 | US20070218147 Peroxisome Proliferator-Activated Receptor (Ppar) Activator, and Drugs, Supplements, Functional Foods and Food Additives Using the Same |
| 09/20/2007 | US20070218129 Solid Dispersible and/or Orodispersible Non-Filmy Containing at Least One Type of Active Substance Pharmaceutical Composition and Method for the Preparation Thereof |
| 09/20/2007 | US20070218057 Human Obesity Susceptibility Gene and Uses Thereof |
| 09/20/2007 | US20070218041 Topical composition having undifferentiated plant seed cells and method for using same |
| 09/20/2007 | CA2717249A1 Dibenzyl amine compounds and derivatives |
| 09/20/2007 | CA2717242A1 Dibenzyl amine derivatives as cetp inhibitors |
| 09/20/2007 | CA2646430A1 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders |
| 09/20/2007 | CA2646347A1 Gastric raft composition comprising preferably processed starches for inducing satiety |
| 09/20/2007 | CA2645712A1 Triazole derivative or salt thereof |
| 09/20/2007 | CA2643070A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
| 09/20/2007 | CA2629348A1 Glucagon receptor antagonists, preparation and therapeutic uses |
| 09/19/2007 | EP1835030A1 OB fusion protein compositions and methods |
| 09/19/2007 | EP1834960A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 09/19/2007 | EP1834953A1 Tetrahydropyrane derivatives as 5-lipoxygenase inhibitors |
| 09/19/2007 | EP1834641A1 Use of CRF1 receptor antagonists for preparing a drug for treating metabolic syndrome and/or obesity and/or dyslipoproteinemia |
| 09/19/2007 | EP1834639A1 Remedial agent for fat toxicity |
| 09/19/2007 | EP1833847A2 Methods of treating obesity with combination therapeautics of igf-1 fusion polypeptides |
| 09/19/2007 | EP1833812A1 N-[(4, 5-diphenyl-3-alkyl-2-thienyl) methyl]amine (amide, sulfonamide, carbamate and urea) derivatives as cannabinoid cb1 receptor antagonists |
| 09/19/2007 | EP1833806A1 Oxadiazole derivatives as dgat inhibitors |
| 09/19/2007 | EP1833805A1 New 3-phenylpropionic acid derivatives for the treatment of diabetes |
| 09/19/2007 | EP1833802A2 1,2-diphenyl-imidazole derivatives and their use as cb1 receptor ligands |
| 09/19/2007 | EP1833787A2 Indole derivatives for use as ppar active compounds |
| 09/19/2007 | EP1833780A1 Methods of making pravastatin sodium |
| 09/19/2007 | EP1833473A2 5ht2c receptor modulator compositions and methods of use |
| 09/19/2007 | EP1673338B1 Fatty acid compounds, preparation and uses thereof |
| 09/19/2007 | EP1515975B1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 09/19/2007 | EP1499605B1 NF-KappaB INHIBITORS |
| 09/19/2007 | EP1496907B1 Tyrosine kinase inhibitors |
| 09/19/2007 | EP1490335B1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 09/19/2007 | EP1480976B1 Thiazole derivatives as npy receptor antagonists |
| 09/19/2007 | EP1474396B1 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 09/19/2007 | EP1439841B1 Androgen receptor modulators and methods of use thereof |
| 09/19/2007 | EP1190071B1 17867, a novel human aminopeptidase |
| 09/19/2007 | EP1141003B1 Methods of activation of SGK by phosphorylation. |
| 09/19/2007 | EP0714438B1 A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 09/19/2007 | CN101039945A Pyrazolo[1,5-a]pyrimidine derivatives |
| 09/19/2007 | CN101039941A Aminopiperidine derivatives, preparation thereof and therapeutic use thereof |
| 09/19/2007 | CN101039936A Oxazolo-naphthyl acids as plasminogen activator inhibitor type-1(pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases |
| 09/19/2007 | CN101039908A Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 09/19/2007 | CN101039903A Method and intermediates for the preparation of derivatives of n (1-benzhydrylazetidin-3-yl)-n-phenylmethylsulfonamide |
| 09/19/2007 | CN101039697A Preventive and/or therapeutic agent for diabetes |
| 09/19/2007 | CN101039664A Atmosphere alteration method, and air spray and spray device used therefor |
| 09/19/2007 | CN101039585A Mixture of phytosterol ester(s) and 1,3-diglyceride(s) for use in the treatment of medical conditions |
| 09/19/2007 | CN101037453A Preparation method of gypenoside |
| 09/19/2007 | CN101037438A Compositions useful as inhibitors of GSK-3 |
| 09/19/2007 | CN101037420A New crystal type of netoglitazone and preparation method thereof |
| 09/19/2007 | CN101037416A 2,5,6-three substitution pyrazine derivatives |
| 09/19/2007 | CN101037409A Process for the preparation of n-substituted 2-cyanopyrrolidines |
| 09/19/2007 | CN101036776A Method for preparing Chinese traditional medicine for treating Shangxiao type diabetes |
| 09/19/2007 | CN101036752A Chinese traditional medicine composition |
| 09/19/2007 | CN101036736A Chinese traditional medicines composition took orally for treating hyperlipaemia |
| 09/19/2007 | CN101036726A Myocardial and brain developer and its prepn |
| 09/19/2007 | CN101036714A Medicinal composition for treating and/or preventing diabetes |
| 09/19/2007 | CN101036711A Technique of extracting polysaccharide in rosa laevigata michx |
| 09/19/2007 | CN101036702A Supercritical CO2 liquid method for extracting efficient element of golden buckwheat |
| 09/19/2007 | CN101036700A Health-caring product for reducing blood sugar and the method for preparing the same |
| 09/19/2007 | CN101036692A Application of radix codonopsis and radix astragali in the preparing of medicine for curing diabetes mellitus |
| 09/19/2007 | CN101036687A Gypenosides dropping pills and the method for preparing the same |
| 09/19/2007 | CN101036675A Method for extracting flavonoids from the waxberry core |
| 09/19/2007 | CN101036673A 感冒药 Cold medicine |
| 09/19/2007 | CN101036671A Silkworm health-care product and its preparing process |
| 09/19/2007 | CN101036649A Function of ascomycin used as the immunosuppressor |
| 09/19/2007 | CN101036646A Quassia wood total alkaloid and the medical function of the monocase alkaloid |
| 09/19/2007 | CN101036644A Pharmaceutical composition containing arctigenin and preparation method |
| 09/19/2007 | CN101036643A Pharmaceutical composition containing arctigenin and preparation method |
| 09/19/2007 | CN101036636A Method for increasing the oral bioavailability of S-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino)phenyl]-2-methylpropanethioate |
| 09/19/2007 | CN101036509A Physalis alkekengi can |
| 09/19/2007 | CN101036494A Technique of producing aweto teabag |
| 09/19/2007 | CN101036491A Expectorant and asthma-curing tea |
| 09/19/2007 | CN100338073C Substituted phenylacetic acids |
| 09/19/2007 | CN100338062C Azaindoles as inhibitors of c-Jun N-terminal kinases |
| 09/19/2007 | CN100338040C Xanthine oxidase inhibitors |
| 09/19/2007 | CN100337712C Method of reducing impurity content in aqueous salt solution |
| 09/19/2007 | CN100337665C Oral medicine for treating diabetes |
| 09/19/2007 | CN100337662C Medicinal composition for treating hyperlipemia and its preparing method |
| 09/19/2007 | CN100337626C Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 09/19/2007 | CN100337623C Chinese rose total flavone and its prepn and use |
| 09/18/2007 | USRE39847 Method of treating a systemic disease |
| 09/18/2007 | US7271311 Mammalian model for diabetes |
| 09/18/2007 | US7271266 Sucha as methyl 2-(benzyloxy)-6-(4-chlorophenyl)-5-(phenyl)pyridine-3-carboxylate; For therapy and prophylaxis of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome, stress, epilepsy |
| 09/18/2007 | US7271196 CETP activity inhibitors |
| 09/18/2007 | US7271192 Nitrogen oxide synthase inhibitors; synthesis |
| 09/18/2007 | US7271190 Indazole compounds as β3 adrenoceptor agonist |